Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
Study NCT ID:
NCT01328951
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2011-04-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-04
First Submit QC Date:
None
Study First Post Date:
2011-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-29
Results First Submit QC Date:
None
Results First Post Date:
2016-02-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-06
Last Update Post Date:
2016-10-28
Last Update Post Date Type:
ESTIMATED